Direct Implantation of Rapamycin-Eluting Stents with Bioresorbable Drug Carrier Technology Utilizing the Svelte Coronary Stent-on-a-Wire: 2-Year Follow-Up of the Randomized, Controlled DIRECT II Study
Files
Publication date
2016-11-01
Editors
Advisors
Supervisors
Document Type
Abstract
Metadata
Show full item recordCollections
License
Abstract
Keywords
Citation
Verheye, S, Stella, P, Carrie, D, Khattab, A, Slagboom, T & Bartunek, J 2016, 'Direct Implantation of Rapamycin-Eluting Stents with Bioresorbable Drug Carrier Technology Utilizing the Svelte Coronary Stent-on-a-Wire : 2-Year Follow-Up of the Randomized, Controlled DIRECT II Study', Journal of the American College of Cardiology, vol. 68, no. 18, Suppl. 1 , TCT-456, pp. B183-B184. https://doi.org/10.1016/j.jacc.2016.09.592